TDC
BSX icon

Thompson Davis & Co’s Boston Scientific BSX Stock Holding History

Thompson Davis & Co’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,179
Closed -$297K – 723
2017
Q3 		$297K Buy
10,179
+9,451
+1,298% +$261K 0.53% 39
2017
Q2 		$20K Buy
728
+78
+12% +$2.07K 0.03% 457
2017
Q1 		$16K Buy
+650
New +$15.8K 0.02% 560
2016
Q4 		– Sell
-250
Closed -$6K – 1121
2016
Q3 		$6K Sell
250
-9,347
-97% -$223K 0.01% 780
2016
Q2 		$224K Buy
+9,597
New +$208K 0.36% 73
2014
Q3 		– Sell
-1,000
Closed -$13K – 1145
2014
Q2 		$13K Hold
1,000
– – 0.02% 451
2014
Q1 		$14K Sell
1,000
-2,500
-71% -$32.8K 0.02% 432
2013
Q4 		$42K Buy
+3,500
New +$41.4K 0.06% 260

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Thompson Davis & Co's BSX Position: Q4 2017 in Review

Thompson Davis & Co sold out of Boston Scientific (BSX) in Q4 2017, closing a stake of 10,179 shares — an estimated $297K sold.

Thompson Davis & Co first reported a position in BSX in Q4 2013 and held it in 8 quarters. The position peaked at $297K in Q3 2017. 632 funds tracked by Wall St. Rank hold BSX as of Q4 2017.

  • Thompson Davis & Co reported no remaining Boston Scientific position as of Q4 2017 after selling out during the quarter.
  • Thompson Davis & Co sold 10,179 Boston Scientific shares in Q4 2017, an estimated $297K.
  • Thompson Davis & Co first reported a position in Boston Scientific in Q4 2013 and held it in 8 quarters.
  • Thompson Davis & Co's Boston Scientific position peaked at $297K in Q3 2017.
  • 632 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2017.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.